Clinical trial
Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment
NCT02069860 is registered in ClinicalTrials.gov with Cendres+Métaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment
- Lead sponsor
- Cendres+Métaux
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 4, 2016
- Completion date
- July 12, 2022
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease requiring haemodialysis, hemodialysis access failure (disorder)